Possible mechanisms of disease development in tuberous sclerosis
- 1 January 2008
- journal article
- review article
- Published by Elsevier BV in The Lancet Oncology
- Vol. 9 (1), 73-79
- https://doi.org/10.1016/s1470-2045(07)70411-4
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- S6K1 Regulates GSK3 under Conditions of mTOR-Dependent Feedback Inhibition of AktMolecular Cell, 2006
- Platelet-Derived Growth Factor–Induced p42/44 Mitogen-Activated Protein Kinase Activation and Cellular Growth Is Mediated by Reactive Oxygen Species in the Absence of TSC2/TuberinCancer Research, 2005
- Genetic analysis of Pten and Tsc2 functional interactions in the mouse reveals asymmetrical haploinsufficiency in tumor suppressionGenes & Development, 2005
- A mouse model of cardiac rhabdomyoma generated by loss of Tsc1 in ventricular myocytesHuman Molecular Genetics, 2004
- Abnormal Cortical Cells and Astrocytomas in the Eker Rat Model of Tuberous Sclerosis ComplexEpilepsia, 2004
- The Tumor Promoter 12-O-Tetradecanoylphorbol 13-acetate (TPA) Provokes a Prolonged Morphologic Response and ERK Activation in Tsc2-Null Renal Tumor CellsToxicological Sciences, 2004
- Estrogen-induced Smooth Muscle Cell Growth Is Regulated by Tuberin and Associated with Altered Activation of Platelet-derived Growth Factor Receptor-β and ERK-1/2Journal of Biological Chemistry, 2004
- Rheb is a direct target of the tuberous sclerosis tumour suppressor proteinsNature, 2003
- Loss of heterozygosity in tuberous sclerosis hamartomas.Journal of Medical Genetics, 1996
- Mutation and Cancer: Statistical Study of RetinoblastomaProceedings of the National Academy of Sciences, 1971